EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1) (C-Term) Peptide
EPM2AIP1
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5511870
Quick Overview for EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1) (C-Term) Peptide (ABIN5511870)
Target
EPM2AIP1
(EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Sequence
- EKAFSYLTRN QHTLSQPLTD EHLQALFRVA TTEMEPGWDD LVRERNESNP
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- EPM2AIP1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Background
-
The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless.
Protein Size: 607 -
Gene ID
- 9852
-
NCBI Accession
- NM_014805, NP_055620
-
UniProt
- Q7L775
Target
-
You are here:
